Encoded Therapeutics

top of page

ASGCT 2026: Encoded Therapeutics presented updated clinical data today for its gene therapy program targeting Dravet Syndrome with 52 weeks of follow up

Co-Founder & CEO Kartik Ramamoorthi walks us through the data and describes Encoded's platform, which is designed to get to the right cells specifically within the brain to treat this and other conditions. Coverage brought to you by

Company News

May 13

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

Learn more

bottom of page

ASGCT 2026: Encoded Therapeutics presented updated clinical data today for its gene therapy program targeting Dravet Syndrome with 52 weeks of follow up

Follow BiotechTV

Sponsors

Sponsor Spotlight